Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip navigation

A study looking at quality of life and follow up for men with prostate cancer (PROSPECTIV)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

This study is looking at improving quality of life and follow up care of men with prostate cancer through a nurse led clinic.  

It can be difficult to cope with prostate cancer and its treatment. You may have problems with your bladder, bowels, sex life or tiredness. You may also have emotional, social and relationship problems. All of these can affect your quality of life.

We know from studies that many men with prostate cancer felt that the support and information they received wasn’t adequate. Studies have also shown that GPs could have a greater role in delivering follow up care and that men with prostate cancer would find this acceptable.  

The researchers want to gather information about problems affecting quality of life of men with prostate cancer. And what the men think about the follow up care they have.  

They then want to use this information to set up nurse led clinics in GP surgeries to deliver extra follow up care for men with prostate cancer.  

The aims of this study are to find out

  • How common problems affecting quality of life are for men with prostate cancer
  • About current follow up care
  • How acceptable a nurse led clinic might be

Recruitment

Start 04/02/2013
End 25/10/2013

Phase

Pilot

Who can enter

You may be invited to take part in this study if

  • You are going to a prostate cancer clinic at either Oxford University Hospitals Trust or Cambridge University Hospitals Trust
  • You were diagnosed with prostate cancer between 9 months and 2 years ago
  • Your prostate cancer is stable – your doctor can confirm this

Trial design

This study is in 2 parts. The 1st part of the study will recruit 300 men. In this part, the study team will post a questionnaire to you with a reply paid envelope. The questionnaire will ask how you are feeling in general and about any symptoms you have, or problems caused by your cancer or treatment. It should take about 30 minutes to complete.

The 2nd part of the study is a pilot study. It will recruit 80 men from the 1st part who have problems caused by their prostate cancer or treatment. This part is a randomised trial. You will be put into 1 of 2 groups. Neither you nor your doctor can choose which group you are in. The 2 groups are

  • Usual follow up
  • Nurse appointments in addition to usual follow up

PROSPECTIV study diagram

The additional nurse appointments will take place at a local GP surgery. You can talk about any problems or issues you have. The nurse will give you some forms to take home and fill in. These forms record any health care that you may have during the study that may be due to your prostate condition. For example attending your GP surgery to get a hormone injection, or attending a hospital clinic to talk about the results of your latest blood test.

The nurse will talk to you about how often they need to see you.

After 6 months a member of the study team will phone to find out how you are. After 9 months the team will send you a questionnaire to fill in. This is a shorter version of the questionnaire you filled in at the beginning.

At the end of the study the team will ask a small number of men to take part in an informal interview. They will do this over the phone or at your home. This is to find out your opinions about being in the study and the care you received.

Hospital visits

There are no extra hospital visits if you take part in this study.

Side effects

There are no expected side effects from this study. But some of the questions may cause you to feel worried or distressed. If so, support will be offered.

Location of trial

CLOSED

For more information

Please note: we cannot help you to join a specific trial. Unless we state otherwise in this trial summary, you need to print this page and take it to your own doctor to discuss.

Find out how to join a trial or contact our cancer information nurses for other questions about cancer by phone (0808 800 4040), by email, or at

The Information Nurses
Cancer Research UK
Angel Building
407 St John Street
London
EC1V 4AD

Chief Investigator

Professor Eila Watson

Supported by

Cambridge University Hospitals NHS Foundation Trust
National Institute for Health Research Cancer Research Network (NCRN)
Oxford Brookes University
Oxford University Hospitals NHS Trust
Prostate Cancer UK
Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 31 October 2013